Hospital readmissions following initiation of nebulized arformoterol tartrate or nebulized short-acting beta-agonists among inpatients treated for COPD

BACKGROUND: Inpatient admissions for chronic obstructive pulmonary disease (COPD) represent a significant economic burden, accounting for over half of direct medical costs. Reducing 30-day readmissions could save health care resources while improving patient care. Recently, the Patient Protection an...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Bollu, Vamsi, Ernst, Frank R, Karafilidis, John, Rajagopalan, Krithika, Robinson, Scott B, Braman, Sidney S
Format: Artigo
Idioma:Inglês
Publicat: Dove Medical Press 2013
Matèries:
Original Research
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3858026/
https://ncbi.nlm.nih.gov/pubmed/24353413
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/COPD.S52557
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars